Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study-Reference-Cited by-同舟云学术

Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study

Published:2014-07-09 Issue:7 Volume:4 Page:e005535-e005535
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Hughes S.,Cohen D.,Jaggi R.

Publisher

BMJ

Subject

General Medicine

Reference50 articles.

1. The evolution of trial registries and their use to assess the clinical trial enterprise;Dickersin;JAMA,2012

2. Publication bias, with a focus on psychiatry: causes and solutions;Turner;CNS Drugs,2013

3. The imperative to share clinical study reports: Recommendations from the Tamiflu experience;Doshi;PLoS Med,2012

4. Rethinking credible evidence synthesis;Doshi;BMJ,2012

5. Structure and content of clinical study reports E3. 1995. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E3/E3_Guideline.pdf

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of the incidence of medical serious adverse events in sub-anesthetic ketamine treatment of psychiatric disorders;Journal of Affective Disorders;2024-01

2. Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review;BMJ Medicine;2023-08

3. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials;Journal of Clinical Epidemiology;2023-06

4. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials;BMJ;2023-04-24

5. Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder;The Journal of Sex Research;2023-02-21